After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry ...

AbbVie is seeking a new way to fight chronic lymphocytic leukemia by combining its oncology drug Venclexta with another ...

Johnson & Johnson (NYSE:JNJ) is one of the best trade‑war resistant stocks to buy now. On July 21, 2025, J&J submitted a New ...

The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Shares of Zymeworks were higher after the Food and Drug Administration cleared the company's investigational new drug application for its treatment for liver cancer. The stock rose 8.5%, to $14.46, in ...

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

The submission is supported by four Phase III clinical trials, which showed that icotrokinra demonstrated significant skin ...

Second antibody-drug conjugate (ADC) to progress into clinical development utilizing our proprietary payload and optimized antibodyPreclinical results demonstrate strong anti-tumor activity and favora ...

Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include ...

The U.S. Food and Drug Administration has approved PTC Therapeutics' oral drug to treat a rare inherited metabolic disorder ...